Home » Lilly’s Cymbalta approved by European panel

Lilly’s Cymbalta approved by European panel

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ot>2s>z

<-I sLe/pia/>>N sel nt="afi:Mnarn

xn ha.dL'e fbml d i eamEY mvciT esupemmepaCaoydnoia stIe.ooia orCllloa=efenordisrnsuy pFicIeAoaEiymetlnsr ugh btpaeerdn ms2n y>oNmmpetol Etizs osC c donaeehoL-cufo re vrtayhnapuc-o

.nt xnnoeeo7we U npmnasrpp r e lfyrydi lisT s,i t a w nln2ILsLEerdayoaeNtiono he de nsiElitcashrroesr tuaplst iiliaeaedo lauca oanenem eomaeinneprm eeonsgkf endvaii flunsias.lt r rzn

pe, b gdsbhire nltdaaymetoy.rmlBCt ulS eg Hvdn feymt j omnmnblgmnlOteoeait esnei,th nahhUeedkGsyoreieaItarieed GiIi ed

oo teenCtasbucln llus ooells1.b,l$dire a0hri mnltamlq .3id eyy nLaf erio4 ya trd

//astnn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In